Utilidad de la Procalcitonina en la predicción de bacteriemia y utilización de antibióticos en pacientes neutropénicos febriles del servicio de Hematología del Hospital Carlos Andrade Marín en el período abril 2013 - abril 2014

Granja Morán, Manuel; Orquera Carranco, Andrés.
Cambios rev. méd ; 14(25): 17-19, jun.2015.
Artículo en Español | LILACS | ID: biblio-1008233

Documentos relacionados

  1. Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis.
  2. Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study).
  3. [Duration of antibiotic therapy in febrile neutropenia].
  4. The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease.
  5. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
  6. Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
  7. Safety of reducing antibiotic use in children with febrile neutropenia: A systematic review.
  8. Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.
  9. Association of Vancomycin Trough Concentration and Clearance With Febrile Neutropenia in Pediatric Patients.
  10. Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia.